Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q2 2022 | 2022-02-02 | Future report Set alerts | |
Q1 2022 | 2021-11-03 | Future report Set alerts | |
Q4 2021 | 2021-09-15 | -0.26 | -0.26 |
Q3 2021 | 2021-05-06 | -0.22 | -0.22 |
Q2 2021 | 2021-02-04 | -0.07 | -0.07 |
Q1 2021 | 2020-11-05 | -0.29 | -0.29 |
Q4 2020 | 2020-09-03 | -0.50 | -0.50 |
Q3 2020 | 2020-04-02 | -0.34 | -0.34 |
Q2 2020 | 2020-02-05 | -0.33 | -0.33 |
Q1 2020 | 2019-11-07 | 0.17 | 0.17 |
2014-12-26 | Upgrade | Sidoti | Neutral to Buy | $13.00 to $16.00 |
2014-10-01 | Downgrade | Sidoti | Buy to Neutral | $13.00 |
1970-01-01 |
2014-12-26 | Upgrade | Sidoti | Neutral to Buy | $13.00 to $16.00 |
2014-10-01 | Downgrade | Sidoti | Buy to Neutral | $13.00 |
1970-01-01 | ||||
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In MSON 3 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Fund Advisors | 15570 |
MetLife Securities, Inc | 14000 |
BlackRock Investment Management, LLC | 1041 |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Vizirgianakis Stavros G. | 22.54% (1641078) | MSON / |
MCMANUS MICHAEL A JR President, CEO | 5.10% (371017) | EML / MSON / NVAX / SHLM / |
Voic Daniel VP, R&D and Engineering | 1.96% (142493) | MSON / |
ZAREMBA RICHARD A Senior Vice President and CFO | 1.81% (131523) | MSON / |
MINETTI T GUY | 1.06% (77000) | MSON / |
ALLIGER HOWARD | 0.97% (70400) | MSON / |
Manna Ronald VP, Regulatory Affairs | 0.51% (36875) | MSON / |
Napoli Frank VP, Operations | 0.45% (32500) | MSON / |
Miner Charles | 0.24% (17500) | MSON / |
Ryan Michael C SVP, Medical Division | 0.21% (15000) | MSON / |
GILDEA JOHN | 0.21% (15000) | MSON / |
ONEILL THOMAS F | 0.09% (6300) | ADM / BFIN / MSON / NDAQ / |
PATTON THOMAS M | 0.07% (5000) | CASM / MSON / |
Ludecker Robert S Global VP of Sales & Marketing | 0.04% (2943) | MSON / |
Dwyer Joseph P Interim CFO | 0.02% (1300) | MSON / |
McBrayer Patrick A | 0.02% (1100) | MSON / |